Arvalus Therapeutics
PrivateLast Round
Grant
Apr 4, 2025
Total Funding Raised
$2.51M
Company Overview
Arvalus Therapeutics is a drug discovery company developing Live Biotherapeutic Products (LBPs) to prevent infections before they occur.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Arvalus Therapeutics Comparables
Compare Arvalus Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vedanta Biosciences | 77% | |
| SNIPR Biome | 74% | |
| Eligo Bioscience | 71% | |
Arvalus Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 4, 2025 | ||||
| Grant | Jan 24, 2025 | ||||
| Grant | Dec 21, 2024 |
Arvalus Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| INCATE | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 21, 2024
$11K grant received from INCATE
Arvalus Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Arvalus Therapeutics's valuation, stock price, and market status.